Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Abstract Background Randomized controlled trials have found that once-weekly insulin resulted in greater glycemic control compared to once-daily insulin in patients with type 2 diabetes. However, no direct comparisons have been made between different types of once-weekly insulin thus far. This syste...
Main Authors: | Peng Wang, Yu Zhang, Wenhao Xu, Jialing He, Liyuan Peng, Yuning Feng, Ping Xu, Weelic Chong, Yang Hai, Lu Jia, Fang Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13098-023-01240-5 |
Similar Items
-
Icodec insulin - revolution in diabetes type 2 insulin therapy
by: Michał Dobrzyński, et al.
Published: (2022-08-01) -
Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
by: Syed Zia Saleem, et al.
Published: (2024-04-01) -
Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
by: Rodrigo Ribeiro e Silva, et al.
Published: (2023-06-01) -
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications
by: Ylenia Ingrasciotta, et al.
Published: (2024-04-01) -
Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
by: Han Na Jang, et al.
Published: (2019-12-01)